Abstract: A resin composition for laminate, which comprises 100 parts by weight of a composition (B), from 0.5 to 10 parts by weight of dicyandiamide and from 1 to 100 parts by weight of a linear polymer, said composition (B) comprising (i) a composition (A) comprising from 20 to 80 parts by weight of a polyfunctional epoxy compound of the formula: ##STR1## wherein R is H or CH.sub.3 and n is an integer of from 0 to 5, and from 80 to 20 parts by weight of an epoxy compound having two epoxy groups in one molecule, and (ii) an aromatic diamino compound incorporated in the composition (A) in such an amount that its active hydrogen is from 0.3 to 0.8 equivalent per equivalent of terminal epoxy groups.

Abstract: A polycarbonate having a principal chain comprising a repeating unit represented by the formula: ##STR1## (a) a substituted phenoxy group represented by the formula (II) ##STR2## (wherein A is as defined in the appended specification) and (b) p-tert-butyl phenoxy group represented by the formula (III) ##STR3## and/or the phenoxy group represented by the formula (IV) ##STR4## bonded to the terminals thereof in the ratio of (a) 10 to 99 mole percent of the said substituted phenoxy group, and (b) 90 to 1 mole percent of p-tert-butylphenoxy group and/or phenoxy group. This polycarbonate has so high a fluidity and an impact resistance that it is moldable into thin or complex shapes.

Abstract: A composition which is curable to an elastomer comprising:A polymer or mixture of polymers of the formula ##STR1## wherein: X are monovalent moieties having ethylenic unsaturation which can be the same or different;Y are divalent linking groups which can be the same or different;m is an integer of 0 to 1;D are monovalent moieties which can be the same or different selected from the group consisting of hydrogen, an alkyl group of 1 to about 10 carbon atoms, aryl, and substituted aryl;R are divalent hydrocarbon groups which can be the same or different;R.sup.1 are monovalent moieties which can be the same or different selected from the group consisting of alkyl, substituted alkyl, aryl, and substituted aryl;R.sup.2 are monovalent moieties which can be the same or different selected from the group consisting of alkyl, substituted alkyl, aryl, and substituted aryl;R.sup.

Abstract: This invention discloses elastomer-forming compositions which have a low viscosity in the uncured state while retaining good physical properties when cured. They comprise an .alpha.,.omega. hydroxyl, trialkoxy or alkylenetrialkoxy end-blocked polydiorganosiloxane, a MQ silicone resin having tetrafunctional units of the formula SiO.sub.2 and monovalent units of the formula R.sub.a R'.sub.3-a SiO.sub.1/2 wherein R' denotes a group of the general formula --R"Si(OR.sup.*).sub.3, with R" being an alkylene group and R.sup.* an alkyl group and wherein a has a value of 2 or 3, preferably 2 for up to 30% of all monovalent units and a titanium catalyst.

Abstract: Low viscosity, crosslinkable polysilanes that are liquid at ambient temperatures and essentially free of volatiles, well adapted for conversion into silicon carbide ceramics at elevated temperatures, are prepared by (a) reacting at least one silane monomer of the formula (1):R.sup.1 R.sup.2 SiCl.sub.2 (1)in which R.sup.1 is a hydrogen atom or a hydrocarbon radical and R.sup.2 is a vinyl radical, with at least one organic or organosilicon monochlorinated comonomer, in the presence of molten sodium in an organic solvent and wherein the ratio r.sub.1 of the number of moles of the silane monomer of formula (1) to the number of moles of the monochlorinated comonomer ranges from 0.

Abstract: A process for preparing polyacetals having less than 10% by weight carbonyl containing units and in which the molar ratio of acetal to furan units is greater than or equal to 15:1 is provided. The process comprises reacting a linear alternating polymer of carbon monoxide with one or more olefins (polyketone) with a diol at elevated temperature in the presence of an acid e.g. para-toluenesulphonic acid while continuously removing water generated by the reaction. Water is preferably removed by azeotropic distillation using a water-immiscible solvent.

Abstract: A vinyl chloride resin for safety glass, comprising either particles of a copolymer of a vinyl chloride monomer and an epoxy-containing monomer, having a particle diameter up to 5 .mu.m and a greater epoxy content in an outer portion than in a an inner portion of the particles, or agglomerates of the particles, and process for the preparation of this resin, comprising either adding an epoxy-containing monomer into a polymerization reaction mixture of a vinyl chloride monomer substantially during a latter half of the polymerization reaction of the polymerization mixture or adding an epoxy-containing monomer and a vinyl chloride monomer either in the form of a mixture solution or separately but at the same time into a polymerization mixture of the vinyl chloride monomer.

Abstract: A novel polyethynylacetylene derivative represented by the formula ##STR1## wherein R is H, (C1-7) alkyl, phenyl, benzyl, naphthyl, carbazole, (C2-7) vinyl-alkyl --CX.sub.1 X.sub.2 (OH) or --SiX.sub.1 X.sub.2 X.sub.3 in which X.sub.1, X.sub.2 and X.sub.3 are H, (C1-7) alkyl, phenyl or benzyl, with the proviso that the case where all of X.sub.1, X.sub.2 and X.sub.3 are H is excluded and x is a number of 20 to 500. The polyethynylacetylene derivative is prepared by polymerizing a monomer of the formula HC.tbd.C--C.tbd.CR wherein R is as defined above, with the proviso that the case where R is H is excluded, in the presence of a metathesis catalyst or a Ziegler catalyst. A polyethynylacetylene derivative of the above formula (wherein R=H) is prepared by reacting a polyethynylacetylene derivative of the above formula wherein R=Si(C.sub.n H.sub.2n+1).sub.3 with a desilylating agent. The polyethynylacetylene derivative is soluble in organic solvents and can be shaped into various articles.

Abstract: This invention provides novel azlactone-functional oligomers of 2-alkenyl azlactones in which oligomerization has occurred predominantly via the 2-alkenyl group. Oligomerization of the 2-alkenyl group provides oligomers having 2 to 15 mer units with predominantly carbon-carbon backbone segments. Oligomerized in this fashion, the novel compositions possess azlactone groups which can be reacted with nucleophiles in the normal ring-opening sense. The oligomers are prepared by a novel process in which both Lewis and Bronsted acidic catalysts are effective. The reactive oligomers find utility as crosslinking agents for polymers containing azlactone-reactable nucleophilic groups.

Abstract: Silica supported high activity olefin polymerization catalysts, methods of producing the catalysts and methods of using the catalysts in the polymerization of olefins are provided. The methods of producing the catalysts each basically comprise contacting a particulate silica support impregnated with tungsten oxide with the soluble complex produced by heating a mixture of a metal dihalide with a transition metal compound to produce a solid, and then reacting the solid with an organoaluminum halide. The catalysts produced have improved productivities and are less soluble in polymerization media.

Abstract: This invention relates to water-soluble allylphosphonate copolymers which are useful for treating aqueous systems. The allylphosphonate copolymers are characterized as having the formula: ##STR1## wherein the molar percentage of x in the copolymer is from 1 to 90 percent, the molar percentage of y in the copolymer is from 10 to 99 percent, and the total of x and y being 100 percent; and wherein each R.sup.1 is independently selected from the group consisting of hydrogen, lower alkyl groups having from 1 to about 4 carbon atoms and a salt forming cation, R.sup.2 and R.sup.3 are independently selected from the group consisting of hydrogen, halogen, COOH, CH.sub.2 COOH, lower alkyl groups having from 1 to about 4 carbon atoms, and phenyl, and A is selected from the group consisting of COOH, CH.sub.2 COOH, .phi.COOH, SO.sub.3 H, CH.sub.2 SO.sub.3 H, CH(CH.sub.3)SO.sub.3 H, CH.sub.2 OCH.sub.2 CH(OH)CH.sub.2 SO.sub.3 H, .phi.-SO.sub.3 H, ##STR2## wherein n=2 to 4, CONH.sub.2, CONHCHH.sub.3, CON(CH.sub.3).sub.

Abstract: A resin composition for use as a paint contains a copolymer prepared by copolymerizing a monomer (I) represented by the following formula (I): ##STR1## wherein either one of X.sub.1 and X.sub.2 stands for an acryloyloxy or methacryloyloxy group, the other being a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R.sub.1 to R.sub.10 each stand for a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and n is an integer of 1 to 4; with an .alpha.,.beta.-ethylenically unsaturated monomer having a reactive functional group and an .alpha.,.beta.-ethylenically unsaturated monomer having no reactive functional group. A monomer mixture for preparing the copolymer contains 5 to 95 wt % of the monomer (I).

Abstract: The present invention relates to a series of novel silicone phosphobetaines which are high foaming low irritation surface active agents that are substantive to fiber and hair. The compounds, because they contain a pendant ionizable phosphate group and a quatarnary amine compound are amphoterics that is they contain both a positive and negative charge in the same molecule. Since the compounds of the present invention are high molecular weight silicone polymers, they have a high degree of oxidative stability, even at elevated temperatures. In addition, these compounds are non volatile and nonirritating. These combination of properties makes these polymers ideally suited for use in personal care applications.

Abstract: The invention relates to new aromatic/aliphatic and/or alicyclic copolyester amides with high molecular weights, without crosslinking. A subsequent solid phase condensation is avoided or is greatly limited in time. The occurrence of thermal decomposition reactions, dark discolorations of the polymers as well as the formation of block structures are avoided.

Abstract: This invention relates to novel furan polyols, which are characterized in that they are the product of reaction of a strain selected from the group or consisting of a polyalcohol, a monoamine or polyamine, said polyalcohol or said amine possibly containing a furan cycle and mixtures thereof with a chain extension agent constituted by an organic epoxide, with the proviso that this organic epoxide is a furannic oxiran when this polyalcohol does not contain a furan cycle with the exclusion of 2,5(bis-hydroxy)furan as sole strain, when the chain extension agent does not contain any furan cycle. These furan polyols are used for the preparation of polyurethane foams having improved properties.

Abstract: Herein disclosed are a polyisocyanato-isocyanurate represented by the following formula (I): ##STR1## wherein n is an integer ranging 1 to 5 and R.sub.1, R.sub.2 and R.sub.3, may be the same or different and each represents hydrogen atom or a lower alkyl group and a method for preparing it; and a resin containing an organic polyisocyanate containing not lower than 10% by weight of the polyisocyanato-isocyanurate represented by Formula (I) and a compound having at least two active hydrogen atoms as well as a resin composition for coating materials which comprises the resin.

Abstract: The present invention relates to heat-curable reaction systems prepared by mixing (a) solid polyisocyanates (optionally deactivated) having melting points above 80.degree. C., (b) OH- and/or NH.sub.2 -terminated polyoxyalkylene polyethers that have molecular weights of 400 to 10,000 and are liquid at room temperature, (c) solid OH- and/or NH.sub.2 -terminated polyesters that have molecular weights of 400 to 20,000 and are solid at room temperature, and which are thoroughly distributed throughout the mixture but are not homogeneously miscible with the polyether, (d) optional low molecular weight chain-extending agents that contain OH and/or NH.sub.2 groups and have a molecular weight of 62 to 399, and (e) optional catalysts and other auxiliaries. The invention further relates to a method for preparing elastomers, coating compounds, sealing compounds, or adhesives by heat-curing the heat-curable systems.

Abstract: The present invention describes the use of 1,3-dialkylimidazole-2-thiones as a catalyst for epoxy/anhydride reactions (and other reactions) and a method of making these catalysts. Epoxy/anhydride coatings containing these improved catalysts offer the following advantages: improved appearance (especially since even weeks after application the coatings still have a "wet" look); better pot-life; improved resistance to alkaline substances which will improve durability; improved solubility; and coatings which have a reduced volatile organic content (VOC).

Abstract: A process for preparing phenol-formaldehyde resole resins and adhesive compositions in which portions of the phenol normally contained in said resins are replaced by a phenol/neutral fractions extract obtained from fractionating fast-pyrolysis oils.

Abstract: Polybenzazole polymers contain perfluorocyclobutane rings to provide a flexible moiety which is stable at high temperatures.

Abstract: This invention provides a process for producing 2H-1-benzopyran-2-ones (coumarins) from optionally-substituted o-halocinnamic acids or esters under polyester-forming conditions. When the coumarins contain appropriately reactive functional groups, and desired monomers are present, a colored or UV-absorbing coumarin/polyester copolymer is provided in one step.

Abstract: The present invention relates to a tetraketone of the structure ##STR1##wherein M is a metal atom and R is selected from phenyl, alkyl substituted phenyl or halogen substituted phenyl. The process to prepare this tetraketone is disclosed. The present invention also relates to a process to produce the tetraketone structure(I). The present invention also relates to the novel polymer of the structure: ##STR2##and to the process to produce this novel polymer. R is as defined hereinabove, and Ar is a tetraamine substituted organic moiety having at least one aromatic ring. These polymers are useful as liquid crystals and in non-linear optical devices.

Abstract: A continuous polymerization device is equipped with a stirring mechanism which possesses a drive shaft parallel to the direction of flow, a multiple number of polymerization precursor supply ports in the direction of flow, and at least one polymerization product output port at its latter portion, and possessing mixing capability with respect to the radial direction while possessing no actual mixing capability with respect to the direction of flow, in a continuous polymerization device which functions by piston flow.

Abstract: The invention is a method of producing a polyester filament which has a superior combination of tensile, dyeability and shrinkage properties. The method comprises forming a polyester-polyethylene glycol copolymer from a mixture consisting essentially of a terephthalic acid or dimethyl terephthalate, ethylene glycol, and polyethylene glycol, with the polyethylene glycol having an average molecular weight of between about 200 and 1500 grams per mole and being added in an amount sufficient to produce a polyester-polyethylene glycol copolymer in which the polyethylene glycol is present in an amount of between about 1.0 and 4 percent by weight of the copolymer formed; forming filament from the copolymer drawing the copolymer filament; and heat setting the drawn filament. The invention also comprises the enhanced fiber formed by the process.

Abstract: Polyimides having a high thermal and oxidative stability are prepared by reacting a mixture of monomers comprising (a) a dialkyl, trialkyl, or tetraalkylester of an aromatic tetracarboxylic acid, (b) an aromatic diamine, and (c) an end cap compound. The ratio of (a), (b), and (c) is chosen so that upon heating the mixtures, low molecular weight prepolymers are formed, the prepolymers having only one end cap radical and being suitable for chain extension and crosslinking to form high molecular weight, thermally stable polyimides. Upon heating, the prepolymers form polyimide resins, which can have T.sub.g in excess of 600.degree. F. and superior physical properties.

Abstract: An improved process for the production of linear alternating polymers of carbon monoxide and hydrocarbon norbornene-type compounds comprises contacting the monomers in the presence of a catalytic quantity of a catalyst composition formed from a palladium compound, the anion of a strong non-hydrohalogenic acid and a bidentate ligand of phosphorus under polymerization conditions including a polymerization temperature above 100.degree. C. In an alternate modification, lower .alpha.-olefin is included in the reaction mixture and additional polymeric products are obtained.

Abstract: An improved process for the production of linear alternating polymers of carbon monoxide and at least one ethylenically unsaturated hydrocarbon of at least 3 carbon atoms employs a novel catalyst composition formed from a palladium compound, the anion of a strong non-hydrohalogenic acid, an aliphatic bidentate ligand of phosphorus and a polyalkoxyalkane.

Abstract: This invention relates to a process of modifying the crystallization temperature (T.sub.cc) of polymers, such as polyesters or polyamides, the polymers produced by this process and the molding compositions containing these polymers. The process comprises cooling a polymer to a temperature sufficient to allow grinding of the polymer to an effective particle and then grinding said polymer to the effective particle size in order that the polymer exhibits an increased T.sub.cc.

Abstract: A poly(arylene sulfide ketone) or poly(arylene sulfide diketone) resin having improved handling characteristics is prepared by a process comprising preparing in a first enclosed vessel a slurry comprising a solid poly(arylene sulfide ketone) or poly(arylene sulfide diketone) resin and a liquid polar organic compound, and optionally water; then substantially liquifying the resin to form a mixture comprising substantially liquified resin and polar organic compound; then flashing the mixture into a second vessel having a pressure lower than the first vessel, thereby removing a portion of the polar organic compound and solidifying the resin.When the slurry further comprises water, the invention method optionally includes a venting step prior to the substantial liquification of the resin and/or a concentration step after the substantial liquification of the resin.

Abstract: New analogues of thymopentin (TP5) and of its tetrapeptide fragment (TP5.sup.1-4) containing two non-contiguous retro-inverted bonds in the peptide chain are described.The new compounds, of general formula (I) ##STR1## where R is hydrogen or an acyl radical, andR.sup.1 is an --OR.sup.2 group or an ##STR2## group where R.sup.2 is a hydrogen atom or a hydrocarbon radical, and R.sup.3 is a hydrogen atom or a hydroxyl group,and the corresponding pharmaceutically acceptable salts of acid or basic addition, possess immunomodulating activity.

Abstract: Lymphokine activated killer suppressive factor (LAKSF) and a process for producing the LAKSF by cultivating human mono-cytic cells for alveolar macrophages activated by a stimulator to produce LAKSF and harvesting it. The LAKSF has a LAK induction suppressive activity and an immunosuppressive effect and thus the LAKSF is useful as a medicine.

Abstract: The subject invention relates to a fibrinogen-specific monoclonal antibody wherein said monoclonal antibody: (a) binds to the isolated A.alpha. chain of fibrinogen, (b) does not prolong the conversion time of fibrinogen to fibrin by thrombin, (c) binds to fibrin and (d) does not crossreact with plasmin derived fibrinogen degradation products. The subject invention also covers the use of such a monoclonal antibody in an immunoassay for the determination of plasma fibrinogen levels in vitro.

Abstract: Disclosed are a family of synthetic proteins having affinity for a preselected antigen. The proteins are characterized by one or more sequences of amino acids constituting a region which behaves as a biosynthetic antibody binding site (BABS). The sites comprise 1) non-covalently associated or disulfide bonded synthetic V.sub.H and V.sub.L dimers, 2) V.sub.H -V.sub.L or V.sub.L -V.sub.H single chains wherein the V.sub.H and V.sub.L are attached by a polypeptide linker, or 3) individuals V.sub.H or V.sub.L domains. The binding domains comprise linked CDR and FR regions, which may be derived from separate immunoglobulins. The proteins may also include other polypeptide sequences which function e.g., as an enzyme, toxin, binding site, or site of attachment to an immobilization media or radioactive atom. Methods are disclosed for producing the proteins, for designing BABS having any specificity that can be elicited by in vivo generation of antibody, and for producing analogs thereof.

Abstract: Chelated radionuclide compositions are provided for conjugation to polypeptides and carbohydrates. The resulting conjugates may be used in diagnosis and therapy.

Abstract: A new process for the preparation of substituted 2,4-diamino-6-flurotriazines of the formula ##STR1## in which the substituents have the meanings given in the description, comprises reacting ammonium salts of the formula ##STR2## in an aqueous medium at pH values of about 2.5-10 with 2,4,6-trifluorotriazine in a continuous process. The reaction products can be converted to dyestuffs without isolating the intermediates.

Abstract: Reactive dyes useful for dyeing or printing hydroxyl- or amino-containing organic substrates have the formula ##STR1## where R.sup.1, R.sup.2 and R.sup.3 are each hydrogen, C.sub.1 -C.sub.4 -alkyl or phenyl,R.sup.4 is C.sub.1 -C.sub.4 -alkoxy, phenoxy or a radical of the formula NL.sup.1 L.sup.2, where L.sup.1 and L.sup.2 are each substituted or unsubstituted C.sub.1 -C.sub.4 -alkyl or substituted or unsubstituted phenyl, or L.sup.1 and L.sup.2 together combine with the nitrogen atom joining them to form a heterocyclic radical, or L.sup.1 may also be hydrogen,R.sup.5 is fluorine, chlorine, bromine, C.sub.1 -C.sub.4 -alkylsulfonyl, phenylsulfonyl or a radical of the formula ##STR2## A is substituted or unsubstituted C.sub.2 -C.sub.8 -alkylene, Y is vinyl or a radical of the formula --CH.sub.2 --CH.sub.

Abstract: The invention relates to novel azo dyes of the formula ##STR1## wherein R.sup.1 is an alkyl radical containing 1 to 12 carbon atoms, which is unsubstituted or substituted by hydroxy, alkoxy, cyano or phenyl, or is an aryl radical selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, 2-pyridyl, 4-pyridyl, 2-pyrimidinyl and 2-thienyl, these radicals being unsubstituted or substituted by halogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro, cyano, --NHR.sup.3, --NH--C.sub.2 -C.sub.6 alkanoyl,--NH--benzoyl, phenoxy, COOR.sup.3, --CONHR.sup.3, phenyl, sulfo or C.sub.1 -C.sub.4 alkylsulfone,R.sup.2 is hydrogen or a radical as defined for R.sup.1,R.sup.3 is hydrogen, C.sub.1 -C.sub.6 alkyl, which is unsubstituted or substituted by hydroxy, alkoxy, cyano or phenyl, or phenyl which is unsubstituted or substituted by halogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro, cyano, --NH--C.sub.2 -C.sub.6 alkanoyl, --NH--benzoyl, phenoxy, phenyl, sulfo or C.sub.1 -C.sub.

Abstract: The present invention provide transcriptional control regions, expression vectors comprising said regions, mammalian cells transformed to transcribe and express genes from said vectors, and various methods of assaying compounds for hormone agonist or antagonist activity, all based on discovery of response elements of the .beta.-retinoic acid receptor and of the activation of said response elements in all mammalian cells without need to transform the cells to express the receptor independently of endogenous expression thereof.

Abstract: The present invention includes nucleotide compositions having linking groups and the use and manner of making the nucleotide compositions. The nucleotide compositions are used to attach nonisotopic label moieties to nucleic acid probes.

Abstract: Finely particulate cellulose esters of aromatic or aromatic-aliphatic carboxylic acids in the form of substantially spherical, partially crystalline particles having an average diameter of 1 to 200 .mu.m and a specific surface area of 10 to 300 m.sup.2 /g, are suitable for use as stationary phase in methods of chromatographic separation, especially for the resolution of racemates.

Abstract: Compounds of the general formula I ##STR1## in which R.sup.1 represents a hydrogen atom or an alkyl group of the formula CH.sub.3 (CH.sub.2).sub.n --where n=0 to 5,R.sup.2 represents a hydrogen atom when X is a carbamoyl group, an alkyl group having 1 to 6 carbon atoms, a group, bonded in an ether-like fashion, of the formula R.sup.3 --O--CH.sub.2 --(CHR.sup.4).sub.m --CH.sub.2 -- in whichR.sup.3 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms,R.sup.4 is a hydroxyl group or an alkyloxy group having 1 to 3 carbon atoms, and m is 0 to 2, represents a group, bonded in an ether-like fashion, of the formula H--(CH.sub.2).sub.a --(O--(CH.sub.2).sub.b).sub.c -- where a=0 to 4, b=1 to 4 and c=1 to 7, orR.sup.2 represents a radical, bonded in a O-glycoside fashion of the formula ##STR2## in whichR.sup.5, R.sup.6 and R.sup.7, independently of one another, are a hydrogen atom or a hydroxyl group, andR.sup.

Abstract: Retinoic esters of D-desosamine have the formula ##STR1## wherein the ##STR2## radical is (all trans) retinoyl, (13 cis) retinoyl or etretinoyl, and R.sub.2 represents linear or branched alkyl having 1-24 carbon atoms; and the .alpha. and .beta. anomers, their mixtures and their salts.These esters are usefully employed in human and veterinary medicines and in cosmetic compositions.

Abstract: The invention relates to certain derivatives of mitomycins A and C and the use thereof to treat bacterial infections and to supress the growth of cancer cells. The invention also relates to processes for the preparation of the mitomycin derivatives of the invention.

Abstract: Salbostatin, a compound of the formula I ##STR1## acts as a glycosidase inhibitor and is suitable for use in pharmacy and in plant protection.

Abstract: The crystalline monohydrate, mono (N,N'-dimethylformamide) and bis(N,N'-dimethylformamide) solvates of 7.beta.-[2'-(R)-2'-(p-hydroxyphenyl-2'-amino-acetamido]-3-chloro-3-(1-carb adethiacephem)-4-carboxylic acid ("LY213735") are novel compounds with superior physical characteristics. Also described are pharmaceutical formulations of crystalline LY213735 monohydrate.

Abstract: Biologically active, enantiomerically substantially pure intermediates of trans-hexahydro-benzo[d]naphtho[2,1-b]azepines are prepared.The present invention involves a process for preparing compounds of the general formula 3: ##STR1## wherein: R* is ##STR2## Each R.sup.1 is independently H or alkyl; Q is methylene, --O-- or --S--;m and n are independently variable and may each have a value of 0, 1 or 2, with the provisos that the sum of m and n is not greater than 3, that m may not equal zero when Q is --O-- or --S--, and that when Q is --CH.sub.2 --, m and n cannot both be zero;X is hydrogen, halo, alkyl, alkylthio, alkylsulfinyl, alkylsufonyl, hydroxy, alkoxy or trifluoromethyl;Y is hydrogen, hydroxy, alkoxy, --OC(O)NR.sup.2 R.sup.3, --OC(O)--R.sup.9, --N(R.sup.1).sub.2, --NHC(O)R.sup.1 or --OP(O)(OH)OR.sup.1,R.sup.2 and R.sup.3 are the same or different and each is hydrogen (provided that both are not hydrogen), alkyl, aralkyl, cycloalkyl, aryl, hydroxyalkyl, or alkoxyalkyl;in addition, when one of R.sup.

Abstract: The present invention provides phospholipase substrates of the general formula: ##STR1## wherein A is an alkylene or alkenylene radical containing up to 16 carbon atoms, R is a hydrgen atom or an alkyl, alkenyl or acyl radical containing up to 20 carbon atoms or an optionally alkyl-substituted aryl or aralkyl radical containing up to 8 carbon atoms in the alkyl moiety, X is the residue of an aromatic hydroxy or thiol compound and each Y, independently of one another, is an oxygen or sulphur atom and Z is --SO.sub.3.sup..crclbar. or a radical of the general formula: ##STR2## wherein R.sup.1 can be a hydrogen atom or a radical of the general formula --(CH.sub.2).sub.n NR.sub.3.sup.2, in which n is 2, 3 or 4 and R.sup.2 is a hydrogen atom or a methyl radical, or is an inositol or serine (--CH.sub.2 --CH(NH.sub.2)--COOH) or glycerol residue.The present invention also provides a process for the optical determination of phospholipases using these substrates, as well as a reagent containing them.

Abstract: Compounds having .alpha. adrenergic activity and useful for the treatment of glaucoma, renal and gastrointestinal disorders and vasoconstictors have the formula ##STR1## where R.sub.1 is independently H, or lower alkyl or 1 to 6 carbons; R.sub.2 is independently H, or lower alkyl of 1 to 6 carbons or the two R.sub.2 symbols jointly represent a carbonyl oxygen; R.sub.3 is H, lower alkyl of one to 6 carbons, O, OH and OR.sub.7 where R.sub.7 is lower alkyl of 1 to 6 carbons, or R.sub.3 is COH or COR.sub.8 where R.sub.8 is lower alkyl of 1 to 6 carbons; R.sub.4 and R.sub.5 independently is H, Br, Cl, or lower alkyl of 1 to 6 carbons, lower alkenyl or lower alkynyl with the proviso that when the R.sub.2 groups symbolize a carbonyl oxygen then R.sub.4 and R.sub.5 both cannot be hydrogen; R.sub.6 is hydrogen, Br, Cl, or lower alkyl of 1 to 6 carbons, lower alkenyl or lower alkynyl, and the R.sub.

Abstract: Herbicidal substituted sulphonylaminoazoles of the formula ##STR1## in which R.sup.1 is optionally substituted alkyl, aralkyl, aryl or heteroaryl,R.sup.2 is hydrogen or --SO.sub.2 --R.sup.1,R.sup.3 is hydrogen, halogen, hydroxyl, mercapto, amino, or an optionally substituted alkyl, alkoxy, alkylthio, alkylamino or dialkylamino radical,A is CH, nitrogen or,at least one of A, D and E is ##STR2## and the others may be that or CH or nitrogen, and X, Y and Z each is nitrogen or optionally substituted C, and salts thereof.

Abstract: The invention relates to a new process for the preparation of compounds of the general Formula I ##STR1## /wherein R stands for piperazinyl, 4-methyl-piperazinyl or 4-ethyl-piperazinyl group/ and pharmaceutically acceptable salts thereof which comprises reacting a compound of the general Formula II ##STR2## /wherein R.sup.1 and R.sup.2 stand for halogen, for an aliphatic acyloxy group containing 2 to 6 carbon atoms and optionally substituted by halogen, or for an aromatic acyloxy group containing 7 to 11 carbon atoms/ with a piperazine derivative of the general Formula ##STR3## /wherein R.sup.3 stands for hydrogen, methyl or ethyl/ or a salt thereof and subjecting the compound of the general Formula IV ##STR4## thus obtained /wherein R, R.sup.1 and R.sup.2 are as stated above/ to hydrolysis after or without isolation and if desired converting the compound of the general Formula I thus obtained into a salt thereof or setting free the same from its salt.